13F Holdings
中文EN

Octagon Capital Advisors LP

NEW YORK NY · SEC CIK 0001839435

2026Q22026Q1 9 earlier quarters 🔒
$1.11B2026Q2 reported value
27Positions
78.5%Top 10 weight · largest 16.1%
5 / 7New / sold out
Reported value over time$1.11B2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

DNTH 16.1%
DFTX 12.5%
ABVX 11.9%
COGT 8.2%
ALMS 7.2%
AVBP 6.2%
TSHA 5.9%
BIOA 3.9%
MIRM 3.6%
KYMR 3.2%

2026Q2 top buys estimated at quarter-end value

ABVX Added+$42.11M
DFTX Added+$23.99M
SMMT New+$18.21M
ANL New+$10.75M
PHVS Added+$10.09M

2026Q2 top sells estimated at quarter-end value

CENTESSA PHARMAC Sold out-$29.79M
KALVISTA PHARMAC Sold out-$29.19M
TERNS PHARMACEUT Sold out-$27.94M
TRVI Reduced-$21.82M
KYMR Reduced-$13.19M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
DNTH DIANTHUS THERAPEUTICS INC $179.53M16.14%1,841,667 -105,000-5.4% -$10.24M Reduced
DFTX DEFINIUM THERAPEUTICS INC $138.77M12.47%2,950,000 510,00020.9% $23.99M Added
ABVX ABIVAX SA $132.33M11.89%993,000 316,00046.7% $42.11M Added
COGT COGENT BIOSCIENCES INC $90.94M8.17%2,350,000 00.0% — Unchanged
ALMS ALUMIS INC $79.66M7.16%2,830,700 00.0% — Unchanged
AVBP ARRIVENT BIOPHARMA INC $68.47M6.15%1,971,054 00.0% — Unchanged
TSHA TAYSHA GENE THERAPIES INC $66.01M5.93%9,693,244 833,3339.4% $5.67M Added
BIOA BIOAGE LABS INC $42.84M3.85%1,748,000 00.0% — Unchanged
MIRM MIRUM PHARMACEUTICALS INC $39.68M3.57%338,900 00.0% — Unchanged
KYMR KYMERA THERAPEUTICS INC $35.55M3.20%310,000 -115,000-27.1% -$13.19M Reduced
AKTS AKTIS ONCOLOGY INC $30.97M2.78%960,847 00.0% — Unchanged
XENE XENON PHARMACEUTICALS INC $29.58M2.66%490,000 00.0% — Unchanged
— ERASCA INC Call $22.99M2.07%1,255,000 1,255,000— $22.99M New
PALI PALISADE BIO INC $21.48M1.93%10,276,317 00.0% — Unchanged
OCUL OCULAR THERAPEUTIX INC $20.38M1.83%2,075,000 -1,091,600-34.5% -$10.72M Reduced
IRON DISC MEDICINE INC $19.75M1.78%270,000 00.0% — Unchanged
SMMT SUMMIT THERAPEUTICS INC $18.21M1.64%1,250,000 1,250,000— $18.21M New
PHVS PHARVARIS N V $15.79M1.42%456,721 291,721176.8% $10.09M Added
ANL ADLAI NORTYE LTD $10.75M0.97%934,716 934,716— $10.75M New
DTIL PRECISION BIOSCIENCES INC $10.61M0.95%1,350,000 -886,732-39.6% -$6.97M Reduced
DBVT DBV TECHNOLOGIES S A $9.42M0.85%574,200 00.0% — Unchanged
FTH FAETH THERAPEUTICS INC $9.03M0.81%361,010 361,010— $9.03M New
— GYRE THERAPEUTICS INC $6.29M0.57%954,416 954,416— $6.29M New
TRVI TREVI THERAPEUTICS INC $5.87M0.53%315,000 -1,170,000-78.8% -$21.82M Reduced
— UNICYCIVE THERAPEUTICS INC $4.69M0.42%1,000,000 00.0% — Unchanged
— CONTEXT THERAPEUTICS INC $1.69M0.15%3,050,000 -2,200,000-41.9% -$1.22M Reduced
— GOSSAMER BIO INC $1.28M0.11%7,750,000 00.0% — Unchanged
— CENTESSA PHARMACEUTICALS PLC $00.00%0 -750,000-100.0% -$29.79M Sold out
— KALVISTA PHARMACEUTICALS INC $00.00%0 -1,450,000-100.0% -$29.19M Sold out
— TERNS PHARMACEUTICALS INC $00.00%0 -530,000-100.0% -$27.94M Sold out
BBOT BRIDGEBIO ONCOLOGY THERAPEUT $00.00%0 -719,000-100.0% -$6.44M Sold out
LXEO LEXEO THERAPEUTICS INC $00.00%0 -1,100,000-100.0% -$6.31M Sold out
CATX PERSPECTIVE THERAPEUTICS INC $00.00%0 -791,555-100.0% -$3.30M Sold out
EVMN EVOMMUNE INC $00.00%0 -143,472-100.0% -$3.30M Sold out